Automated description from the Alliance of Genome Resources (Release 8.3.0)
Predicted to enable several functions, including MDM2/MDM4 family protein binding activity; NF-kappaB binding activity; and enzyme inhibitor activity. Acts upstream of or within negative regulation of G1/S transition of mitotic cell cycle and spleen development. Predicted to be located in mitochondrion; nuclear lumen; and senescence-associated heterochromatin focus. Predicted to be part of protein-containing complex. Predicted to be active in cytoplasm and nucleus. Predicted to colocalize with nuclear body. Is expressed in several structures, including central nervous system; eye; genitourinary system; immune system; and liver. Human ortholog(s) of this gene implicated in several diseases, including breast cancer (multiple); carcinoma (multiple); hematologic cancer (multiple); high grade glioma (multiple); and melanoma (multiple). Orthologous to several human genes including CDKN2B (cyclin dependent kinase inhibitor 2B).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.